The largest database of trusted experimental protocols

Amersham ecl plus detection reagents

Manufactured by GE Healthcare

Amersham ECL Plus Detection Reagents are a chemiluminescent detection system used for the quantitative analysis of proteins in Western blotting procedures. The reagents generate a luminescent signal when combined with the target protein, allowing for sensitive and accurate detection.

Automatically generated - may contain errors

2 protocols using amersham ecl plus detection reagents

1

Quantitative Western Blot Analysis of sFRP4

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein homogenates were prepared with a standard radioimmunoprecipitation assay buffer supplemented by protease and phosphatase inhibitor cocktails as previously described (17 (link)). Unless otherwise specified, 45 mg of protein per well was loaded onto 12% Bis-Tris polyacrylamide gels (Invitrogen, Carlsbad, CA) and transferred to nitrocellulose membranes. Nonspecific binding was blocked with 5% nonfat dried milk suspended in Tris-buffered saline (pH 7.2) supplemented with 0.1% Tween-20 (Sigma, St. Louis, MO). Polyclonal antibody specific for sFRP4 was obtained from Abcam (Cambridge, MA) and used at 1:1000 dilution. Horseradish peroxidase–conjugated secondary antibody (Sigma-Aldrich, St. Louis, MO) was used at 1:500 dilution. Immunoreactivity was visualized with Amersham ECL Plus Detection Reagents (GE Life Sciences, Piscataway, NJ). GAPDH was used as a loading control for all experiments. Anti-GAPDH polyclonal antibody was obtained from Sigma and used at 1:1000 dilution. Results of Western blots were quantified via a LICOR Odyssey Fc Imaging system, normalized to expression of the GAPDH loading control by defining a uniform region of interest.
+ Open protocol
+ Expand
2

Cardiomyocyte Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were extracted from the cardiomyocytes cultured at Day 1 and Day 4 and separated by electrophoresis in sodium dodecyl sulfate polyacrylamide gel. The α-actinin and MyHC were immunolabeled with antibodies, (including anti-α-actinin [Abcam] and anti-MyHC [eBioscience]) after being transferred to a polyvinylidene fluoride membrane, and then, the proteins were labeled with HRP-conjugated secondary antibodies and detected with Amersham ECL Plus™ Detection Reagents (GE) followed by exposure and image development.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!